Categories: DeliveryDevelopmentDrugFinTechMedtechProductionWebsite
Attgeno is a pharmaceutical company based in Stockholm, Sweden.
The company is developing a novel nitric oxide donor called Supernitro for the treatment of acute pulmonary hypertension caused by cardiovascular or pulmonary diseases. Supernitro will be the first and only intravenous drug to selectively treat acute high blood pressure in the lungs
YEAR OF INVESTMENT
2018
SECTOR
Drug development
LOCATION
Stockholm, Sweden
WEBSITE
https://attgeno.com/
Investors 2
Mentions in press and media 2
Reviews 0
